Powered by

Surmodics Receives FDA 510(k) Clearance for Pounce(TM) Thrombus Retrieval System; Next-generation technology provides easy, effective clot removal from peripheral arterial vasculature

Sep 23, 2020 - Business Wire

Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Pounce(TM) Thrombus Retrieval System.

The Pounce Thrombus Retrieval System is intended for the non-surgical removal of thrombi and emboli from the peripheral arterial vasculature. Depending on the age and magnitude of the occlusion and the viability of the threatened l...